Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss

NCT ID: NCT04090801

Last Updated: 2019-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-30

Study Completion Date

2017-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will be included 60 women with FPHL. The diagnosis of FPHL will be established by clinical (Ludwig classification) and trichoscopic evaluation of frontal and occipital regions of the scalp.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Enrolled women will be randomly assigned into 3 treatment groups: group A will apply topical minoxidil 5% in 90% ethanol and 5% propylene glycol, group B will apply topical minoxidil 5% in pure ethanol alone and group C will apply pure ethanol (placebo) twice daily.

The treatment will be continued for six months with regular visits at 3 months intervals.

The medications will be provided in bottles which were identical in shape and color, and were coded by a third party.

Both patients and investigator will be blinded to the medication. Disclosure of the codes will be done, by a third party, at the end of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Pattern Hair Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study will be to compare the efficacy of topical minoxidil 5% solution in ethanol plus 5% propylene glycol (PG), as a vehicle, versus 5% minoxidil in ethanol alone in treatment of women with FPHL.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors
The medications will be provided in bottles which will be identical in shape and color, and will be coded by a third party. Both patients and investigator will be blinded to the medication. Disclosure of the codes will be done, by a third party, at the end of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Topical minoxidil 5% in 90% ethanol and 5% propylene glycol

Group A applied topical minoxidil 5% in 90% ethanol and 5% propylene glycol

Group Type ACTIVE_COMPARATOR

Topical minoxidil 5% in 90% ethanol and 5% propylene glycol

Intervention Type DRUG

Topical minoxidil 5% in pure ethanol alone

Group B applied topical minoxidil 5% in pure ethanol alone

Group Type ACTIVE_COMPARATOR

Topical minoxidil 5% in pure ethanol alone

Intervention Type DRUG

The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.

Placebo

Group C applied pure ethanol (placebo)

Group Type PLACEBO_COMPARATOR

Placebo (Ethanol)

Intervention Type OTHER

The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Topical minoxidil 5% in 90% ethanol and 5% propylene glycol

Intervention Type DRUG

Topical minoxidil 5% in pure ethanol alone

The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.

Intervention Type DRUG

Placebo (Ethanol)

The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Topical minoxidil 5% with 90% ethanol and 5% propylene glycol Topical minoxidil 5%

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* FPHL

Exclusion Criteria

* No
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammed Abu El-Hamd

Assistant Professor of Dermatology, Venereology and Andrology Department, Faculty of Medicine, Sohag University, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed Abu El-Hamd, MD

Role: PRINCIPAL_INVESTIGATOR

Faculty of Medicine, Sohag University, Egypt.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5/2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.